By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally view D-Wave's $100 million CHIPS Act letter of intent as a non-dilutive equity purchase, but they caution that it's not a revenue or product contract, and the deal's closing conditions, milestones, and use-of-funds constraints are unclear. The market's 33% pop reflects sentiment rather than fundamentals, and the company remains pre-commercial at scale with significant commercialization hurdles and cash burn.
Risk: The deal's closing conditions, milestones, and use-of-funds constraints are unclear, and the company's lack of proven advantage on industrially relevant problems could hinder enterprise buying cycles.
Opportunity: The deal could unlock parallel non-dilutive awards under the National Quantum Initiative Act, potentially preserving shareholder value.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
D-Wave stock surged today following news that the company is on track to receive CHIPS Act funding.
D-Wave is set to receive $100 million for the sale of new stock to the U.S. Department of Commerce.
D-Wave Quantum (NYSE: QBTS) stock closed out Thursday's trading session with massive gains. The company's share price gained 33.4% in the daily session.
The quantum computing specialist's valuation surged following news that the company is on track to receive funding through the CHIPS and Science Act. Even with today's massive pop, D-Wave stock is still down roughly 1% year to date.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
With a press release it published today, D-Wave announced that it was on track to receive $100 million in funding through the U.S. Department of Commerce. The company said that it had received a letter of intent for a $100 million investment through the CHIPS Act. In exchange for the funding, D-Wave will provide the Department of Commerce with $100 million worth of shares.
The U.S. government's pending investment in D-Wave represents a significant vote of confidence in the quantum-computing specialist. While the investment hasn't been closed yet, it seems very likely that the deal will go through. With the Department of Commerce seemingly set to invest $100 million in D-Wave through the CHIPS Act, the quantum-computing company has seemingly secured major backing from a very powerful and influential source. While the outlook for D-Wave and the broader semiconductor space remains highly speculative, growing support from the U.S. government is a very positive development.
Before you buy stock in D-Wave Quantum, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and D-Wave Quantum wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $475,063! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,369,991!
Now, it’s worth noting Stock Advisor’s total average return is 994% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 21, 2026. *
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The equity-based CHIPS funding for QBTS risks shareholder dilution without guaranteeing near-term revenue or technological breakthroughs."
D-Wave's $100 million CHIPS Act letter of intent from the Department of Commerce drove QBTS up 33.4% on equity issuance rather than a grant. While this injects capital and signals federal interest in quantum annealing, the deal dilutes shareholders at current prices and ties funding to a program designed primarily for semiconductor fabs. Quantum computing still lacks clear commercial timelines or recurring revenue, leaving QBTS exposed to execution risk and sector hype cycles even after the pop. Year-to-date performance remains flat despite the headline.
The government stake could attract follow-on private capital and accelerate hardware milestones, turning the dilution into a net positive if D-Wave secures major enterprise contracts within 18 months.
"A letter of intent for government equity investment is political/strategic validation, not proof of commercial product-market fit or a path to profitability."
The $100M CHIPS Act letter of intent is real validation, but it's structurally a non-dilutive equity purchase by Commerce—not revenue or a product contract. D-Wave gets capital; the government gets shares at today's prices. The 33% pop reflects sentiment, not fundamentals. Critically: QBTS remains pre-commercial at scale. No mention of when this closes, what milestones trigger it, or whether Commerce can walk away. The article conflates government backing with commercial viability. YTD flat performance despite the pop suggests the market has priced in quantum hype cycles before.
If D-Wave's quantum systems are actually approaching utility on real problems—and Commerce wouldn't commit $100M without technical due diligence—this could be the inflection point from vaporware narrative to credible player, justifying a re-rating even before revenue scales.
"The market is conflating government interest with commercial viability, ignoring that this funding is a dilutive equity issuance that does not solve the company's core profitability issues."
The market is misinterpreting this $100 million 'investment' as a growth catalyst, when it is essentially a government-backed equity dilution event. While the CHIPS Act involvement signals geopolitical relevance and potential long-term R&D support, D-Wave (QBTS) remains a cash-burning entity with significant commercialization hurdles. A 33% move on a letter of intent—not a closed deal—suggests retail-driven momentum rather than institutional conviction. Investors are ignoring the underlying dilution; issuing $100 million in new shares at these depressed levels significantly caps future upside for existing shareholders. Until D-Wave demonstrates a clear path to positive EBITDA, this is a speculative play on government policy, not fundamental value.
The government's involvement provides a 'de-risking' signal that could attract private capital and anchor the company as a strategic national asset, potentially leading to a higher valuation floor than the market currently assumes.
"The strongest risk is that the LOI does not close or carries heavy conditions, leading to dilution and overhang that likely eclipses any short-term pop."
The article frames a $100 million CHIPS Act investment as a near-certain, equity-friendly windfall for D-Wave (QBTS). In reality, government funding rarely comes as immediate equity funding, and closing conditions, milestones, and use-of-funds constraints can stall or derail deals. Even with a letter of intent, the company faces brutal burn, limited revenue visibility, and a nascent market for quantum hardware adoption. A one-day 33% rally is momentum-driven, not earnings-driven, and dilution or delayed funding could wipe out near-term gains. Absent a clear, binding path to funded growth, the stock remains highly speculation-driven.
If the LOI proves binding and comes with favorable terms, the equity infusion could materially de-risk the narrative and sustain a longer rally, making the stock move more than just a momentary spike.
"The LOI could trigger additional non-dilutive federal quantum funding that offsets equity dilution."
Gemini flags dilution correctly but overlooks how this CHIPS Act LOI could unlock parallel non-dilutive awards under the National Quantum Initiative Act. D-Wave might pair the equity raise with DoD or NSF contracts that preserve shareholder value. The larger unmentioned risk is technical: annealing hardware still lacks proven advantage on industrially relevant problems versus gate-model systems, so government capital alone may not shift enterprise buying cycles.
"The LOI's lack of disclosed milestones and closing conditions is a bigger red flag than the dilution itself."
Grok's NQI parallel-funding angle is credible but speculative—no evidence D-Wave has secured DoD/NSF commitments. More pressing: all four panelists accept the $100M as quasi-certain, but LOIs routinely collapse on milestones or appropriations delays. Commerce hasn't disclosed closing conditions, timeline, or whether funds vest on hardware delivery or just equity purchase. That opacity matters more than dilution math right now. Until we see binding terms, this is a sentiment trade, not a capital event.
"The government will likely subsidize D-Wave regardless of commercial viability to maintain a domestic quantum industrial base, potentially creating a long-term zombie stock."
Claude is right about the LOI opacity, but everyone is missing the geopolitical floor. This isn't just about D-Wave; it's about the US government preventing a 'quantum gap' with China. Even if the tech is inferior to gate-model systems, the government will subsidize D-Wave to maintain a domestic annealing capability. The risk isn't the deal collapsing—it's that the 'strategic asset' status keeps the company on life support while commercial utility remains years away, creating a permanent zombie stock.
"The stock's upside is capped by policy risk more than by tech risk."
Gemini's geopolitics-as-floor thesis is a plausible tail risk, but it risks becoming a governance trap. Government backing can lock QBTS into a policy-driven capital cycle with few enterprise contracts, delaying real profitability. If milestones slip or budgets shift, the LOI could devolve into a funding cliff, not a catalyst. In that outcome, the stock’s upside is capped by policy risk more than by tech risk.
The panelists generally view D-Wave's $100 million CHIPS Act letter of intent as a non-dilutive equity purchase, but they caution that it's not a revenue or product contract, and the deal's closing conditions, milestones, and use-of-funds constraints are unclear. The market's 33% pop reflects sentiment rather than fundamentals, and the company remains pre-commercial at scale with significant commercialization hurdles and cash burn.
The deal could unlock parallel non-dilutive awards under the National Quantum Initiative Act, potentially preserving shareholder value.
The deal's closing conditions, milestones, and use-of-funds constraints are unclear, and the company's lack of proven advantage on industrially relevant problems could hinder enterprise buying cycles.